JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M413525200 on December 22, 2004

J. Biol. Chem., Vol. 280, Issue 9, 8324-8331, March 4, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/9/8324    most recent
M413525200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ehirchiou, D.
Right arrow Articles by Zhang, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ehirchiou, D.
Right arrow Articles by Zhang, L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Dual Function for a Unique Site within the {beta}2I Domain of Integrin {alpha}M{beta}2*

Driss Ehirchiou{ddagger}, Yu-Mei Xiong{ddagger}, Yang Li{ddagger}, Shelesa Brew§, and Li Zhang, An established investigator of the American Heart Association{ddagger}

From the Departments of {ddagger}Physiology and §Biochemistry, University of Maryland School of Medicine, Rockville, Maryland 20855

Integrin activation has been postulated to occur in part via conformational changes in the I domain of the {beta} subunit (the {beta}I domain), especially near the F-{alpha}7 loop, in response to "inside-out" signaling. However, direct evidence for a role of the F-{alpha}7 loop in ligand binding and activity modulation is still lacking. Here, we report our finding that the F-{alpha}7 loop (residues 344–358) within the {beta}2I domain has dual functions in ligand binding by {alpha}M{beta}2. On the one hand, it supports intercellular adhesion molecule 1 (ICAM-1) binding to {alpha}M{beta}2 directly as part of a recognition interface formed by five noncontiguous segments (Pro192–Glu197, Asn213–Glu220, Leu225–Leu230, Ser324–Thr329, and Glu344–Asp348) on the apex of the {beta}2I domain. On the other hand, it controls the open and closed conformation of the {alpha}M{beta}2 receptor, thereby indirectly affecting {alpha}M{beta}2 binding to other ligands. Switching the five constituent sequences of the ICAM-1-binding site within the {beta}2I domain to their {beta}1 counterparts destroyed ICAM-1 binding but had no effect on the gross conformations of the receptor. Of the five ICAM-1 binding-defective mutants, four had normal or even stronger interaction with Fg and C3bi, as reported in our previous study. Synthetic peptides derived from the identified site inhibited {alpha}M{beta}2-ICAM-1 interaction and supported direct binding to ICAM-1. Most importantly, perturbation of the F-{alpha}7 loop caused conformational changes within the {beta}2I domain, which was further propagated to other regions of {alpha}M{beta}2. Altogether, our data demonstrate that inside-out signaling could modulate ligand binding directly by changing the ligand-binding pocket per se and/or indirectly by inducing multiple conformational changes within the receptor.


Received for publication, December 1, 2004

* This work was supported in part by NHLBI, National Institute of Health Grant R01 HL61589-01 and by American Heart Association Grant 0240208N. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Dept. of Physiology, University of Maryland School of Medicine, 15601 Crabbs Branch Way, Rockville, MD 20855. Tel.: 301-738-0657; Fax: 301-738-0465; E-mail: ZHANGL{at}USA.REDCROSS.ORG.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. Zhu, B. Boylan, B.-H. Luo, P. J. Newman, and T. A. Springer
Tests of the Extension and Deadbolt Models of Integrin Activation
J. Biol. Chem., April 20, 2007; 282(16): 11914 - 11920.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
V. Gupta, A. Gylling, J. L. Alonso, T. Sugimori, P. Ianakiev, J.-P. Xiong, and M. Amin Arnaout
The {beta}-tail domain ({beta}TD) regulates physiologic ligand binding to integrin CD11b/CD18
Blood, April 15, 2007; 109(8): 3513 - 3520.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.